Kobayashi Pharmaceutical Co. Ltd

Research Kobayashi Pharmaceutical Co. Ltd (KOY) on Bullrun: valuation model: 62.7% overvalued, market cap EUR 2.13B, P/E 102.2, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKOY
• ExchangeF
• CountryJapan
• SectorConsumer Defensive
• IndustryHousehold & Personal Products
• CurrencyEUR
• Valuation signal62.7% overvalued
• Market capEUR 2.13B
• P/E102.2
• Dividend yield2.0%
• Financial periodQ4 2024
• RevenueEUR 51.14B
• Net incomeEUR 4.72B
• Gross margin48.7%

Valuation Snapshot

Bullrun's latest valuation model marks Kobayashi Pharmaceutical Co. Ltd as 62.7% overvalued; latest market cap is EUR 2.13B; P/E is 102.2; dividend yield is 2.0%.

About Kobayashi Pharmaceutical Co. Ltd

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat;

Frequently asked questions

Is Kobayashi Pharmaceutical Co. Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Kobayashi Pharmaceutical Co. Ltd as 62.7% overvalued.

What is Kobayashi Pharmaceutical Co. Ltd's market cap?

Kobayashi Pharmaceutical Co. Ltd's market capitalization is EUR 2.13B.

What is Kobayashi Pharmaceutical Co. Ltd's P/E ratio?

Kobayashi Pharmaceutical Co. Ltd's price-to-earnings (P/E) ratio is 102.2.

Does Kobayashi Pharmaceutical Co. Ltd pay a dividend?

Kobayashi Pharmaceutical Co. Ltd has a dividend yield of 2.0%.

What does Kobayashi Pharmaceutical Co. Ltd do?

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.